Literature DB >> 28032284

Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population.

T-D Li1, J-J Li1,2, X Huang1,3, H Wang1, X-Y Guo1, S-X Ge4, J Zhang5.   

Abstract

Recurrent human cytomegalovirus (HCMV) infection during pregnancy could lead to congenital HCMV infection and permanent sequelae. However, knowledge regarding the risk factors associated with recurrent HCMV infection is limited. In the present study, 1,659 paired serum samples from the natural population were collected in Guangxi Province, China, from 2003 to 2004 with a 1-year interval. The serum anti-pp150 titre was quantitatively determined using a homemade recombinant pp150-based ELISA, and the IgG titre that increased at least 4-fold was defined as a recurrent infection. The HCMV seroprevalence was above 98.6% (1,636/1,659) in Guangxi in 2003, and the infection rate during the 1-year follow-up was approximately 10% (171/1,659). The seronegative population has the highest infection risk, while the risk of recurrent infection in the seropositive population was negatively correlated with the baseline anti-pp150 titre. With a cutoff of 1:80 (the baseline anti-pp150 IgG titre), the sensitivity and specificity were 73.1% (125/171) and 85.7% (1,275/1,488) respectively, and the relative risk of infection in the high-risk group compared to the low-risk group was 10.6 (95% CI: 7.7-14.6). In conclusion, the baseline anti-pp150 IgG was negatively correlated with the risk of HCMV infection and could be an excellent predictor of HCMV infection in HCMV seropositive populations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28032284     DOI: 10.1007/s10096-016-2873-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Development of an enzyme-linked immunospot assay for determination of rotavirus infectivity.

Authors:  Tingdong Li; Haijun Lin; Linqi Yu; Miaoge Xue; Shengxiang Ge; Qinjian Zhao; Jun Zhang; Ningshao Xia
Journal:  J Virol Methods       Date:  2014-08-27       Impact factor: 2.014

2.  Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus.

Authors:  S B Boppana; K B Fowler; W J Britt; S Stagno; R F Pass
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

Review 3.  Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.

Authors:  Yoav Yinon; Dan Farine; Mark H Yudin
Journal:  Obstet Gynecol Surv       Date:  2010-11       Impact factor: 2.347

4.  Passive immunization during pregnancy for congenital cytomegalovirus infection.

Authors:  Giovanni Nigro; Stuart P Adler; Renato La Torre; Al M Best
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

5.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

6.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

7.  Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population.

Authors:  Ping Zhao; Daoxin Ma; Fuzhong Xue; Chunyan Ji; Shukang Wang; Xiaomei Zhang; Yabin Zhou; Xiuping Yu
Journal:  Arch Virol       Date:  2009-03-05       Impact factor: 2.574

8.  Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.

Authors:  Aparecida Yulie Yamamoto; Marisa Marcia Mussi-Pinhata; Suresh B Boppana; Zdenek Novak; Virginia M Wagatsuma; Patricia de Frizzo Oliveira; Geraldo Duarte; William J Britt
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

9.  Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China.

Authors:  Rong-Cheng Li; Sheng-Xiang Ge; Yan-Ping Li; Ying-Jie Zheng; Yi Nong; Qing-Shun Guo; Jun Zhang; Mun-Hon Ng; Ning-Shao Xia
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

10.  Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China.

Authors:  Qi Zhang; Yan Gao; Ying Peng; Miao Fu; Yan-Qing Liu; Qiu-Ju Zhou; Jian Yu; Xiao-Qun Zheng
Journal:  Virol J       Date:  2014-07-04       Impact factor: 4.099

View more
  4 in total

1.  Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.

Authors:  Jingtao Cui; Wenjuan Yan; Hongjie Xie; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Anping Ni
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

2.  Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea.

Authors:  Yeonju La; Da Eun Kwon; Seul Gi Yoo; Kyoung Hwa Lee; Sang Hoon Han; Yong Goo Song
Journal:  BMC Infect Dis       Date:  2019-11-08       Impact factor: 3.090

3.  Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population.

Authors:  Yue Huang; Tingdong Li; Huan Yu; Jiabao Tang; Qiaoqiao Song; Xiaoyi Guo; Han Wang; Caihong Li; Jiangding Wang; Caihong Liang; Xingmei Yao; Lingxian Qiu; Chunlan Zhuang; Zhaofeng Bi; Yingying Su; Ting Wu; Shengxiang Ge; Jun Zhang
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 4.  CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update.

Authors:  Xiao-Hua Luo; Yan Zhu; Yu-Ting Chen; Li-Ping Shui; Lin Liu
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.